检索结果 - Steven I. Blum

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD

    Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD 由 Andrew P. Yu, Annie Guérin, Diego Ponce de Leon, Karthik Ramakrishnan, Eric Q. Wu, Michelle Mocarski, Steven I. Blum, Juliana Setyawan

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial

    Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, rando... 由 David Cella, Robert J. Motzer, Cristina Suárez, Steven I. Blum, Flavia Ejzykowicz, Melissa Hamilton, Joel Wallace, Burçin Şimşek, Joshua Zhang, Cristina Ivanescu, Andrea B. Apolo, Toni K. Choueiri

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back Pain

    Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back Pain 由 Abhilasha Ramasamy, Mona L. Martin, Steven I. Blum, Hiltrud Liedgens, Charles E. Argoff, Rainer Freynhagen, Mark S. Wallace, Kelly P. McCarrier, Donald M. Bushnell, Noël V. Hatley, Donald L. Patrick

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    LBA59 First-line nivolumab (NIVO) + ipilimumab (IPI) combined with 2 cycles of platinum-based chemotherapy (chemo) vs 4 cycles of chemo in advanced non-small cell lung cancer (NSCLC): Patient-reported outcomes (PROs) from CheckMate 9LA

    LBA59 First-line nivolumab (NIVO) + ipilimumab (IPI) combined with 2 cycles of platinum-based chemotherapy (chemo) vs 4 cycles of chemo in advanced non-small cell lung cancer (NSCL... 由 Martin Reck, T. Ciuleanu, Manuel Cobo, Michael Schenker, Bogdan Żurawski, J. Menezes, Eduardo Richardet, Jaafar Bennouna, Ying Cheng, Luis Paz‐Ares, Sheng-Feng Lu, Thomas John, Brad Padilla, Xiaowu Sun, A. Moisei, Jiarui Yan, Yong Yuan, Steven I. Blum, David P. Carbone

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    121P Health-related quality of life (HRQoL) outcomes from CheckMate 77T: Neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant NIVO in resectable NSCLC

    121P Health-related quality of life (HRQoL) outcomes from CheckMate 77T: Neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant NIVO in resectable NSCLC 由 J. Spicer, Mariano Provencio, Mark M. Awad, Jie He, Shun Lu, F. Tanaka, Robin Cornelissen, Luboš Petruželka, Jarosław Kużdżał, Lin Wu, J-L. Pujol, Hiroyuki Ito, T. Ciuleanu, L.D.O.M. Koch, Annelies Janssens, Steven I. Blum, L. Vo, Christoph Erdmann, S. Meadows–Shropshire, Tina Cascone

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649

    Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma... 由 Markus Moehler, Hong Xiao, Steven I. Blum, Elena Elimova, David Cella, Kohei Shitara, Jaffer A. Ajani, Yelena Y. Janjigian, Marcelo Garrido, Lin Shen, Kensei Yamaguchi, Tianshu Liu, Michael Schenker, Rubén Dario Kowalyszyn, Arinilda Bragagnoli, Ricardo Brugés, Vincenzo Montesarchio, Roberto Pazo-Cid, Shannon Hunter, Eric Davenport, Jinyi Wang, Kaoru Kondo, Mingshun Li, Lucjan Wyrwicz

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes

    First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-... 由 Martin Reck, Tudor‐Eliade Ciuleanu, Manuel Cobo, Michael Schenker, Bogdan Żurawski, J. Menezes, Eduardo Richardet, Jaafar Bennouna, Enriqueta Felip, Óscar Juan, Aurelia Alexandru, Ying Cheng, Hiroshi Sakai, Luis Paz‐Ares, Shun Lü, Thomas John, Xiaowu Sun, A. Moisei, Fiona Taylor, Rachael Lawrance, Xiaoqing Zhang, Judi Sylvester, Yong Yuan, Steven I. Blum, John R. Penrod, David P. Carbone

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1

    First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1 由 Martin Reck, Tudor‐Eliade Ciuleanu, Jong Seok Lee, Michael Schenker, Clarisse Audigier-Valette, Bogdan Żurawski, Helena Linardou, Gregory A. Otterson, Pamela Salman, Makoto Nishio, Emmanuel de la Mora Jimenez, Krysztof Lesniewski-Kmak, István Albert, Samreen Ahmed, Konstantinos Syrigos, John R. Penrod, Yong Yuan, Steven I. Blum, Faith E. Nathan, Xiaowu Sun, Alejandro Moreno‐Koehler, Fiona Taylor, Kenneth J. O’Byrne

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227

    Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227 由 Julie R. Brahmer, Jong-Seok Lee, Tudor‐Eliade Ciuleanu, Reyes Bernabé, Makoto Nishio, László Urbán, Clarisse Audigier-Valette, Lorena Lupinacci, Randeep Sangha, Adam Płużański, Jacobus A. Burgers, Mauricio Mahave, Samreen Ahmed, Adam J. Schoenfeld, Luis Paz‐Ares, Martin Reck, Hossein Borghaei, Kenneth J. O’Byrne, Ravi G. Gupta, Judith Bushong, Li Li, Steven I. Blum, Laura J. Eccles, Suresh S. Ramalingam

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: